Tag: Immune Disorders
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
ACR: Incidence of Atrioventricular Block Increased With High Levels of Anti-SSA/Ro Antibodies
Incidence of atrioventricular block increased with higher antibody levels, reaching 7.7 percent in top quartile of anti-60 kD SSA-Ro
COVID-19 podría aumentar el riesgo de trastornos inmunológicos como alopecia y enfermedad de Crohn,...
Un nuevo estudio sugiere que las personas con antecedentes de COVID-19 podrían enfrentar mayores probabilidades de padecer trastornos autoinmunes y autoinflamatorios, incluida la alopecia, la enfermedad de Crohn y la vasculitis.
COVID-19 May Raise Risk for Immune Disorders like Alopecia and Crohn’s, New Study Finds
A new study suggests people with a history of COVID-19 may face increased odds for autoimmune and autoinflammatory disorders, including alopecia, Crohn’s disease and vasculitis.
Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
Risks associated with COVID-19 severity
Efgartigimod Efficacious, Safe for Primary Immune Thrombocytopenia
More patients receiving efgartigimod reached primary end point of sustained platelet count response
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines
Long COVID May Affect More Patients Than Previously Thought
A number of patients with postviral syndrome after suspected COVID-19 have immune responses to SARS-CoV-2
Thymectomy in Adults Linked to All-Cause Mortality, Cancer
Increased risk for autoimmune disease seen when patients with preoperative infection, cancer, autoimmune disease were excluded
Prevalence of Neuropsychiatric Symptoms Up for Autoimmune Rheumatic Disease
More than 50 percent of those with systemic autoimmune rheumatic diseases had never/rarely reported mental health symptoms to clinicians
